AstraZeneca
OpenCalais Metadata: Ticker
AstraZeneca pulls its Covid-19 vaccine from the European market
The pharma giant AstraZeneca has requested that the European authorization for its Covid-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn "at the request of the marketing authorization holder."
Astrazeneca withdraws anti-Covid vaccine that could cause rare thromboses - The reason cited
According to AstraZeneca, the vaccine is being withdrawn for commercial reasons as it "has been overtaken by updated vaccines that address the new Covid-19 variants"
AstraZeneca Initiates Global Recall of COVID-19 Vaccine
In a significant move that reverberates across the global vaccination landscape, pharmaceutical giant AstraZeneca has announced a worldwide recall of its COVID-19 vaccine, citing an abundance of updated vaccine options in the wake of the pandemic's evolution. The decision comes amidst shifting demand dynamics and ongoing scrutiny surrounding the safety profile of the vaccine.
BioNTech’s cancer vaccine succeeds in halting tumor growth
Turkish scientists Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, have announced that their cancer vaccine has succeeded in halting tumor growth and reducing its size in their initial tests.
Cancer drugs might hit the shelves in 2026
Uğur Şahin, one of BioNTech's co-founders, has announced that their company's cancer treatment medicine will hit the shelves as early as 2026.
Şahin, who has been working with his wife Dr. Özlem Türeci for many years on treatments targeting various types of cancers, especially bowel cancer, stated that the drugs they have developed could be on the market in a few years.
- Read more about Cancer drugs might hit the shelves in 2026
- Log in to post comments
Pill halves risk of death in type of lung cancer
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on June 4.
The results were unveiled in Chicago at the largest annual conference of cancer specialists, hosted by the American Society for Clinical Oncology (ASCO).
- Read more about Pill halves risk of death in type of lung cancer
- Log in to post comments
The Supply of COVID Vaccines is already outpacing the Demand
After two years of competing for vaccination against covid in the world, the number of available vaccines is already exceeding their demand. However, there remains a huge difference in vaccination levels between the richest and poorest countries, writes AFP.
Coronavirus: New study by Tsiodras – Lytras – Vaccination prevented almost 20,000 deaths
About 20,000 deaths from complications of Covid-19 were prevented by vaccination against the coronavirus infection, according to a new pre-published study by professors Sotiris Tsiodras and Theodoros Lytras, conducted during the period 11 January 2020 - 8 December 2021.
Only fully vaccinated can enter the country
Under the new rules, only travelers who have received three doses of the coronavirus vaccine can enter the country without additional documents.
According to the new Regulation on the COVID-19 regime for entry into Austria, the list of high-risk countries no longer applies.
- Read more about Only fully vaccinated can enter the country
- Log in to post comments
Bulgarian Prof. Kantardzhiev: Third dose of RNA Vaccine Protects against Omicron
"Because of the new version of Omicron, a third dose of RNA vaccine must be given because it really protects. The first two doses of AstraZeneca protect only 20%.